{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:56:50Z","timestamp":1790632610520,"version":"4.1.0"},"reference-count":38,"publisher":"AOSIS","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South African Family Practice"],"DOI":"10.4102\/safp.v65i1.5644","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T18:40:56Z","timestamp":1686336056000},"source":"Crossref","is-referenced-by-count":3,"title":["Medical practitioners\u2019 knowledge and awareness of multiple myeloma at public hospitals, Gauteng, South Africa"],"prefix":"10.4102","volume":"65","author":[{"given":"Andiswa M.","family":"Pooe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abegail N.","family":"Dlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam T.","family":"Ntuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Silberstein J, Tuchman S, Grant SJ. What is Multiple myeloma? J Am Med Assoc. 2022;327(5):497. https:\/\/doi.org\/10.1001\/jama.2021.25306","DOI":"10.1001\/jama.2021.25306"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Gerecke C, Fuhrmann S, Strifler S, Schmidt-Hieber M, Einsele H, Knop S. The diagnosis and treatment of Multiple myeloma. Dtsch Arztebl Int. 2016;113(27-28):470-476. https:\/\/doi.org\/10.3238\/arztebl.2016.0470","DOI":"10.3238\/arztebl.2016.0470"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Ludwig H, Novis Durie S, Meckl A, Hinke A, Durie B. Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment. Oncologist. 2020;25(9):e1406-e1413. https:\/\/doi.org\/10.1634\/theoncologist.2020-0141","DOI":"10.1634\/theoncologist.2020-0141"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Zhou L, Yu Q, Wei G, et al. Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019. BMC Cancer. 2021;21(1):606. https:\/\/doi.org\/10.1186\/s12885-021-08280-y","DOI":"10.1186\/s12885-021-08280-y"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Palumbo A, Bringhen S, Ludwig H, et al. Personalized therapy in multiple myeloma according to patient age and vulnerability: A report of the European Myeloma Network (EMN). Blood. 2011;118(17):4519-4529. https:\/\/doi.org\/10.1182\/blood-2011-06-358812","DOI":"10.1182\/blood-2011-06-358812"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Ramsenthaler C, Kane P, Gao W, et al. Prevalence of symptoms in patients with multiple myeloma: A systematic review and meta-analysis. Eur J Haematol. 2016;97(5):416-429. https:\/\/doi.org\/10.1111\/ejh.12790","DOI":"10.1111\/ejh.12790"},{"issue":"6","key":"ref6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: A unique malignancy","volume":"43","author":"Kazandjian","year":"2016","unstructured":"Kazandjian D. Multiple myeloma epidemiology and survival: A unique malignancy. Semin Oncol. 2016;43(6):676-681.","journal-title":"Semin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Liu J, Liu W, MI L, et al. Incidence and mortality of multiple myeloma in China, 2006-2016: An analysis of the Global Burden of Disease Study 2016. J Hematol Oncol. 2019;12(1):136. https:\/\/doi.org\/10.1186\/s13045-019-0807-5","DOI":"10.1186\/s13045-019-0807-5"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538-e548. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Fazel F, Bassa F. An approach to the diagnosis and management of multiple myeloma. South African Medical Journal. 2019;109(10):723-727. https:\/\/doi.org\/10.7196\/SAMJ.2019.v109i10.14376","DOI":"10.7196\/SAMJ.2019.v109i10.14376"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Schonfeld SJ, Erdmann F, Wiggill T, et al. Hematologic malignancies in South Africa 2000-2006: Analysis of data reported to the National Cancer Registry. Cancer Med. 2016;5(4):728-738. https:\/\/doi.org\/10.1002\/cam4.597","DOI":"10.1002\/cam4.597"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Oelofse D, Truter I. Incidence of haematological malignancies, Eastern Cape Province; South Africa, 2004-2013. Cancer Epidemiol. 2018;53:166-171. https:\/\/doi.org\/10.1016\/j.canep.2018.01.016","DOI":"10.1016\/j.canep.2018.01.016"},{"key":"ref12","unstructured":"Visser HF, Visser A, Snyckers CH, Goller R, Pool R, Myburgh JG. Retrospective review of multiple myeloma and immunosecretory disorder cases diagnosed in a tertiary setting. SA Orthop J. 2009;8(4), 38-43."},{"key":"ref13","unstructured":"Mwambakana M. The occurrence of adult haematological malignancies at Ga-Rankuwa Hospital [homepage on the Internet]. 2000 [cited 2017 May 15]. Available from http:\/\/ulspace.ul.ac.za\/handle\/10386\/667"},{"key":"ref14","unstructured":"Murakami H, Handa H, Saitoh T. Diagnosis and management guidelines for multiple myeloma. Nihon Rinsho. 2007;65(12):2167-2176."},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Goldschmidt H, Cremer FW, M\u00f6hler TM, Ho AD. Multiple myeloma. Diagnosis and therapy. Internist (Berl). 2003;44(5):599-618. https:\/\/doi.org\/10.1007\/s00108-003-0920-x","DOI":"10.1007\/s00108-003-0920-x"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Kehrer M, Koob S, Strauss A, Wirtz DC, Schmolders J. Multiple myeloma - Current status in diagnostic testing and therapy. Z Orthop Unfall. 2017;155(5):575-586. https:\/\/doi.org\/10.1055\/s-0043-110224","DOI":"10.1055\/s-0043-110224"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Girnius S, Munshi NC. Challenges in multiple myeloma diagnosis and treatment. Leuk Suppl. 2013;2(Suppl 1):S3-S9. https:\/\/doi.org\/10.1038\/leusup.2013.2","DOI":"10.1038\/leusup.2013.2"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Koshiaris C, Oke J, Abel L, Nicholson BD, Ramasamy K, Van den Bruel A. Quantifying intervals to diagnosis in myeloma: A systematic review and meta-analysis. BMJ Open. 2018;8(6):e019758. https:\/\/doi.org\/10.1136\/bmjopen-2017-019758","DOI":"10.1136\/bmjopen-2017-019758"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Acquah ME, Hsing AW, McGuire V, Wang S, Birmann B, Dei-Adomakoh Y. Presentation and survival of multiple myeloma patients in Ghana: A review of 169 cases. Ghana Med J. 2019;53(1):52-58. https:\/\/doi.org\/10.4314\/gmj.v53i1.8","DOI":"10.4314\/gmj.v53i1.8"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA. Variation in several general practitioner consultations before hospital referral for cancer: Findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol. 2012;13(4):353-365. https:\/\/doi.org\/10.1016\/S1470-2045(12)70041-4","DOI":"10.1016\/S1470-2045(12)70041-4"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Lyratzopoulos G, Saunders CL, Abel GA. Are emergency diagnoses of cancer avoidable? A proposed taxonomy to motivate study design and support service improvement. Future Oncol. 2014;10(8):1329-33. https:\/\/doi.org\/10.2217\/fon.14.80","DOI":"10.2217\/fon.14.80"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Kariyawasan CC, Hughes DA, Jayatillake MM, Mehta AB. Multiple myeloma: Causes and consequences of delay in diagnosis. Q J Med. 2007;100(10):635-640. https:\/\/doi.org\/10.1093\/qjmed\/hcm077","DOI":"10.1093\/qjmed\/hcm077"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Thokerunga E, Ntege C, Ahmed AO. Are African primary physicians suspicious enough? Challenges of multiple myeloma diagnosis in Africa. Egypt J Intern Med. 2021;33:54 https:\/\/doi.org\/10.1186\/s43162-021-00088-3","DOI":"10.1186\/s43162-021-00088-3"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"McShane CM, Murphy B, Lim KH, Anderson LA. Monoclonal gammopathy of undetermined significance as viewed by haematology healthcare professionals. Eur J Haematol. 2018;100(1):20-26. https:\/\/doi.org\/10.1111\/ejh.12962","DOI":"10.1111\/ejh.12962"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"McShane CM, Murphy B, Santin O, Anderson LA. Low knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners. BMC Fam Pract. 2019;20(1):61. https:\/\/doi.org\/10.1186\/s12875-019-0944-5","DOI":"10.1186\/s12875-019-0944-5"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Oduor MA, Lotodo TC, Vik TA, et al. Building a sustainable comprehensive Multiple myeloma program in Western Kenya. JCO Glob Oncol. 2021;7:400-407. https:\/\/doi.org\/10.1200\/GO.20.00572","DOI":"10.1200\/GO.20.00572"},{"key":"ref27","unstructured":"Nwabuko CO, Nnoli MA, Igbigbi EE. Plasma cell [8] myeloma: Challenges in diagnosis in sub-Saharan Africa. Jokull J. 2015;65(1):254-266."},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Dhodapkar MV. MGUS to myeloma: A mysterious gammopathy of underexplored significance. Blood. 2016;128(23):2599-2606. https:\/\/doi.org\/10.1182\/blood-2016-09-692954","DOI":"10.1182\/blood-2016-09-692954"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Van Nieuwenhuijzen N, Spaan I, Raymakers R, Peperzak V. From MGUS to multiple myeloma, a paradigm for clonal evolution of premalignant cells. Cancer Res. 2018;78(10):2449-2456. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3115","DOI":"10.1158\/0008-5472.CAN-17-3115"},{"key":"ref30","unstructured":"Ogunmefun C, Moyo S, Mbatha T, Madale R, English R. Gauteng province 2008-2010 [homepage on the Internet]. 2012 [cited 2023 Feb 04]. Durban: Health systems trust. Available from https:\/\/vdocuments.mx\/district-hospital-performance-assessment-gauteng-province-publicationsdistrict.html?page=1"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Zhang Z. Model building strategy for logistic regression: Purposeful selection. Ann Transl Med. 2016;4(6):111. https:\/\/doi.org\/10.21037\/atm.2016.02.15","DOI":"10.21037\/atm.2016.02.15"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Bird J, Behrens J, Westin J, et al. UK Myeloma Forum (UKMF) and Nordic Myeloma study group (NMSG): Guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol. 2009;147(1):22-42. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07807.x","DOI":"10.1111\/j.1365-2141.2009.07807.x"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Pawlyn C, Jackson GH. Physicians, paraproteins and progress: Diagnosis and management of myeloma. Br J Hosp Med (Lond). 2019;80(2):91-98. https:\/\/doi.org\/10.12968\/hmed.2019.80.2.91","DOI":"10.12968\/hmed.2019.80.2.91"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/bjc.2012.408","article-title":"Routes to diagnosis for cancer - Determining the patient journey using multiple routine data sets","volume":"107","author":"Elliss-Brookes","year":"2012","unstructured":"Elliss-Brookes L, McPhail S, Ives A, et al. Routes to diagnosis for cancer - Determining the patient journey using multiple routine data sets. Br J Cancer. 2012;107:1220-1226.","journal-title":"Br J Cancer"},{"key":"ref35","unstructured":"Pouye A, Ka MM, Dia D, et al. Diagnosis delay of multiple myeloma: Report of 22 cases in an internal medicine department of Dakar. Dakar Med. 2004;49(2):132-135."},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Manyega KM, Lotodo TC, Oduor MA, et al. Retrospective analysis of presentation, treatment, and outcomes of Multiple myeloma at a large public referral hospital in Eldoret, Kenya. JCO Glob Oncol. 2021;7:391-399. https:\/\/doi.org\/10.1200\/GO.20.00573","DOI":"10.1200\/GO.20.00573"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Friese CR, Abel GA, Magazu LS, Neville BA, Richardson LC, Earle CC. Diagnostic delay and complications for older adults with multiple myeloma. Leuk Lymphoma. 2009;50(3):392-400. https:\/\/doi.org\/10.1080\/10428190902741471","DOI":"10.1080\/10428190902741471"}],"container-title":["South African Family Practice"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T08:24:42Z","timestamp":1744791882000},"score":1,"resource":{"primary":{"URL":"https:\/\/safpj.co.za\/index.php\/safpj\/article\/view\/5644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,6,15]]}},"URL":"https:\/\/doi.org\/10.4102\/safp.v65i1.5644","relation":{},"ISSN":["2078-6204","2078-6190"],"issn-type":[{"value":"2078-6204","type":"electronic"},{"value":"2078-6190","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,15]]}}}